Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of a 4 Year Combination Therapy of Growth Hormone and Gonadotropin- Releasing Hormone Agonist in Children With a Short Predicted Height.

NCT00840944 is registered in ClinicalTrials.gov with Belgian Study Group for Pediatric Endocrinology as lead sponsor.

NCT NCT00840944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00840944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of a 4 Year Combination Therapy of Growth Hormone and Gonadotropin- Releasing Hormone Agonist in Children With a Short Predicted Height.
Lead sponsor
Belgian Study Group for Pediatric Endocrinology
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2008
Completion date
April 30, 2024
Enrollment
44 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic short stature